| Product Code: ETC7538456 | Publication Date: Sep 2024 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India blood disorder therapeutics market import shipments surged with a robust CAGR from 2020 to 2024. However, growth slowed notably between 2023 and 2024. Despite the slight dip, the market exhibited strong expansion momentum over the period, indicating a promising overall trend.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Blood Disorder Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Blood Disorder Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Blood Disorder Therapeutics Market - Industry Life Cycle |
3.4 India Blood Disorder Therapeutics Market - Porter's Five Forces |
3.5 India Blood Disorder Therapeutics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 India Blood Disorder Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of blood disorders in India |
4.2.2 Rising awareness about blood disorders and available treatment options |
4.2.3 Technological advancements in blood disorder therapeutics |
4.3 Market Restraints |
4.3.1 High cost associated with blood disorder therapeutics |
4.3.2 Limited access to healthcare facilities in certain regions of India |
4.3.3 Stringent regulatory requirements for approval of new blood disorder treatments |
5 India Blood Disorder Therapeutics Market Trends |
6 India Blood Disorder Therapeutics Market, By Types |
6.1 India Blood Disorder Therapeutics Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Blood Disorder Therapeutics Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 India Blood Disorder Therapeutics Market Revenues & Volume, By Plasma Derived Factors, 2021- 2031F |
6.1.4 India Blood Disorder Therapeutics Market Revenues & Volume, By Recombinant Factors, 2021- 2031F |
6.1.5 India Blood Disorder Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 India Blood Disorder Therapeutics Market Import-Export Trade Statistics |
7.1 India Blood Disorder Therapeutics Market Export to Major Countries |
7.2 India Blood Disorder Therapeutics Market Imports from Major Countries |
8 India Blood Disorder Therapeutics Market Key Performance Indicators |
8.1 Number of patients diagnosed with blood disorders receiving treatment |
8.2 Adoption rate of new blood disorder therapeutics in the market |
8.3 Rate of successful treatment outcomes for blood disorders |
8.4 Number of clinical trials conducted for innovative blood disorder treatments |
8.5 Patient satisfaction and quality of life improvement after receiving blood disorder therapeutics |
9 India Blood Disorder Therapeutics Market - Opportunity Assessment |
9.1 India Blood Disorder Therapeutics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10 India Blood Disorder Therapeutics Market - Competitive Landscape |
10.1 India Blood Disorder Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Blood Disorder Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |